TSH and FT4 reference intervals in pregnancy: a systematic review and individual participant data meta-analysis

Joris A J Osinga, Arash Derakhshan, Glenn E Palomaki, Ghalia Ashoor, Tuija Männistö, Spyridoula Maraka, Liangmiao Chen, Sofie Bliddal, Xuemian Lu, Peter N Taylor, Tanja G M Vrijkotte, Fang-Biao Tao, Suzanne J Brown, Farkhanda Ghafoor, Kris Poppe, Flora Veltri, Lida Chatzi, Bijay Vaidya, Maarten A C Broeren, Beverley M ShieldsSachiko Itoh, Lorena Mosso, Polina V Popova, Anna D Anopova, Reiko Kishi, Ashraf Aminorroaya, Maryam Kianpour, Abel López-Bermejo, Emily Oken, Amna Pirzada, Marina Vafeiadi, Wichor M Bramer, Eila Suvanto, Jun Yoshinaga, Kun Huang, Judit Bassols, Laura Boucai, Ulla Feldt-Rasmussen, Elena N Grineva, Elizabeth N Pearce, Erik K Alexander, Victor J M Pop, Scott M Nelson, John P Walsh, Robin P Peeters, Layal Chaker, Kypros H Nicolaides, Mary E D'Alton, Tim I M Korevaar

    23 Citationer (Scopus)

    Abstract

    CONTEXT: Interpretation of thyroid function tests during pregnancy is limited by the generalizability of reference intervals between cohorts due to inconsistent methodology.

    OBJECTIVE: (1) To provide an overview of published reference intervals for thyrotropin (TSH) and free thyroxine (FT4) in pregnancy, (2) to assess the consequences of common methodological between-study differences by combining raw data from different cohorts.

    METHODS: (1) Ovid MEDLINE, EMBASE, and Web of Science were searched until December 12, 2021. Studies were assessed in duplicate. (2) The individual participant data (IPD) meta-analysis was performed in participating cohorts in the Consortium on Thyroid and Pregnancy.

    RESULTS: (1) Large between-study methodological differences were identified, 11 of 102 included studies were in accordance with current guidelines; (2) 22 cohorts involving 63 198 participants were included in the meta-analysis. Not excluding thyroid peroxidase antibody-positive participants led to a rise in the upper limits of TSH in all cohorts, especially in the first (mean +17.4%; range +1.6 to +30.3%) and second trimester (mean +9.8%; range +0.6 to +32.3%). The use of the 95th percentile led to considerable changes in upper limits, varying from -10.8% to -21.8% for TSH and -1.2% to -13.2% for FT4. All other additional exclusion criteria changed reference interval cut-offs by a maximum of 3.5%. Applying these findings to the 102 studies included in the systematic review, 48 studies could be used in a clinical setting.

    CONCLUSION: We provide an overview of clinically relevant reference intervals for TSH and FT4 in pregnancy. The results of the meta-analysis indicate that future studies can adopt a simplified study setup without additional exclusion criteria.

    OriginalsprogEngelsk
    TidsskriftThe Journal of clinical endocrinology and metabolism
    Vol/bind107
    Udgave nummer10
    Sider (fra-til)2925-2933
    Antal sider9
    ISSN0021-972X
    DOI
    StatusUdgivet - 28 sep. 2022

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'TSH and FT4 reference intervals in pregnancy: a systematic review and individual participant data meta-analysis'. Sammen danner de et unikt fingeraftryk.

    Citationsformater